Comprehensive analyses comparing immune cell profiles between synovial tissue and peripheral blood in patients with early, treatment-naïve RA have shown that Tph cell-associated signatures serve as important biomarkers for treatment response and prognosis [43]. The gene discussed is TPH1; the disease is rheumatoid arthritis.